Plasma levels of serpina3g, MMP9, TIMP1, and TIMP2 concentrations are reported higher in COPD patients compared to the controls, and higher levels are observed in COPD groups III and IV than in groups I and II [102]. This evidence concerns the gene MMP9 and chronic obstructive pulmonary disease.